Da det forventes, at et stort antal eksisterende aktive stoffer vil komme i betragtning, har Kommissionen behov for oplysninger for at kunne opstille prioriteringer for den næste fase i undersøgelsesprogrammet, som forventes påbegyndt i 2002.
Given the expected high number of existing active substances which are candidates for such inclusion, information is needed to set priorities for a further phase of the review programme, which is planned to be initiated in 2002.